This inventor holds 1 USPTO granted patent. Top assignee: Zentaris Ag. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Vichai Reutrakul: Innovator in Medicinal Chemistry
Introduction
Vichai Reutrakul is a prominent inventor based in Bangkok, Thailand. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on xanthone compounds. His research focuses on the preparation and application of these compounds as potential medicaments.
Latest Patents
Vichai holds a patent for "Xanthone compounds, their preparation and use as medicament." This invention pertains to novel xanthone compounds, emphasizing the isolation of the natural product sootepenseone from the Annonaceae family. The patent details the identification and derivatization of sootepenseone, highlighting its potential use as an anticancer agent.
Career Highlights
Vichai Reutrakul is associated with Zentaris AG, where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential impact on cancer treatment, showcasing his dedication to improving healthcare through innovative solutions.
Collaborations
Some of Vichai's notable coworkers include Thaiwatchai Santisuk and Gerhard Noessner. Their collaborative efforts contribute to the ongoing research and development of xanthone compounds and their applications in medicine.
Conclusion
Vichai Reutrakul's contributions to the field of medicinal chemistry, particularly through his patent on xanthone compounds, demonstrate his commitment to innovation in healthcare. His work has the potential to lead to significant advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile